California OTC Firm Written Up for Missing Validations, Product Reviews

Drug Industry Daily
A A
The FDA cited an OTC drugmaker in California for violations at its facility involving its manufacturing equipment and quality system.

To View This Article:

Login

Subscribe To Drug Industry Daily